chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had temp & shaking of upper & lower extremities on 24JUN93 was adm to hosp also had acute gastroenteritis;
PATIENT CAME BACK TO PHARMACY WITH A PAINFUL SWOLLEN ARM AT THE INJECTION SITE (LEFT IM). NO OTHER SIGNIFICANT REACTIONS NOTED. PATIENT STATED THAT SHE DID NOT HAVE ANY FEVER OR ANY OTHER PAIN. INFORMED PATIENT THAT THIS IS A SIDE EFFECT OF THE VACCINE AND TO ICE IT AND TO TAKE OTC PAIN MEDICATIONS (I.E. TYLENOL OR MOTRIN). PATIENT SAID SHE WILL ICE IT AND TAKE TYLENOL IF NEED BE.
Initial flu shot lead to acute pain in left shoulder at site of injection.  On 10/6/2015 patient started feeling intense pain in shoulder, radiating down the left arm.  Pain became progressively worse, accompanied by significant muscle weakness in fingers and wrist.  MRI excluded pre-existing spinal steonsis as potential cause.  Presumptive diagnosis was Parsonage-Turner syndrome, treated with oral steroids and narcotic analgesics.  Radial pain has subsided to a low level in response to prednisone, but weakness persists.  EMG studies are planned once prednisone is terminated.
Patient was given a fourth dose of Hep B and 2 doses of IPV which was fourth and fifth doses. No adverse reaction noted.
Patient received expired MODERNA vaccine. The vaccine expired on July 13 2022, contacted patient on 7/28/22 and stated no adverse events.
redness swelling and soreness. symptoms got progressively worse monday into tuesday.  patient tried benadryl. when no improvement she went to MD. md prescribed cephalexin 500mg  every 6 hours and prednisone 20mg  2 tabs daily
Pt reports to ED 1day s/p now w/ L arm stiffness, sore throat, HA, "shivers and chills" w/o relief s/p motrin.
Stiff neck from chin bone to shoulder; Tenderness where she got the shot; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck from chin bone to shoulder) and VACCINATION SITE PAIN (Tenderness where she got the shot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck from chin bone to shoulder) and VACCINATION SITE PAIN (Tenderness where she got the shot). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck from chin bone to shoulder) and VACCINATION SITE PAIN (Tenderness where she got the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
p/vax pt started fever evening of 9/15/99 given APAP;had sz 630AM that day;second ssz 730AM x 1 1/2min;sz aobut 930AM given APAP;taken to ER by amb;another sz;adm to hosp;no further sz;
Pt recv vax on 6/23/98; on same day pt exp fever, not consolable x 1 day, limp/ lethargic, fussy x 2 day
Patient received an adult dose of Pfizer (0.3cc) - should have received Pediatric Pfizer (0.2cc). Patient has not reported any adverse effects.
Copious mucus production and discharge from sinuses and nasal passages.  Mild nausea with a small amount of brief vomiting.  Entire episode lasted 2 hours.  Ended approximately 3:30 AM with no lasting effects.
1 1/2 hrs after receiving immunizations, started crying/irritable. Cried x 10 hrs even after receiving Tylenol without redness at any of immunization sites.
This spontaneous report as received from a nurse practitioner refers to a patient (gender and age not reporter) which was vaccinated with PNEUMOVAX23 (dose and route not provided) which was exposed to 11.5 C for 137.5 hours. No adverse effect reported. Lot number H022281 is an invalid lot number for PNEUMOVAX23. This is one of several reports received from the same source. Additional information is not expected.
SM developed redness, swelling, pain in left arm, within 24 hours of receiving SC anthrax shot.
Patient admitted approximately one week after vaccine administration, and was diagnosed with cerebrovascular accident, Right MCA.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent condition, medical history or concomitant medications were not reported. The nurse reported that on 20-APR-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K009953, expiry date 03-APR-2016 (dose and route of administration unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a health professional refers to a 12 year old patient of unknown gender. On 20-JAN-2016, the patient was vaccinated with a second dose of GARDASIL lot # K008931 (expiration date 04-MAR-2016) (dose, route and site of administration were not reported), which was stored for 15 hours and 15 minutes in a 33 Fahrenheit (F) degrees. There was no previous temperature excursion and the call was not because of a data logger. Additional information is not expected, as all required correspondence was received.
10/18/23 patient reported swollen throat and shortness of breath. This was reported to clinic on 10/24/23. Patient and spouse reported that symptoms went away 2 days after injection.
Pt had Pediarix, Hib and Prevnar immunization today at 9:30am and has been screaming inconsolably for 3 hours. I spoke to dad at 4:30 and she had calmed down.
In past, patient has had very minor tinnitus only experienced in completely silent conditions. In the weeks after receiving vaccine, patient has had continual symptom of high pitch noise that is evident at times, rather than just in silence. It is not debilitating bus is always noticeable.
itching at injection site, dry throat, vomiting, sweating, stomach cramps,  muscle pain/ stiffness in arm and chest, muscle twitching, no appetite, frequent urination, kidney pain, menstrual bleeding, cold sweating, trouble sleeping, inflamed intestines, nausea
I received the 2nd dose of the Pfizer vaccine on 3/2/21. My reactions to the vaccine:   1st dose on 2/9/21: a little sleepy and a bit sore at the site of the injection. Both symptoms were gone within 24 hrs.  2nd dose on 3/2/21: tired and sleepy the next day and a little itchy rash and sore arm at the site of injection that was about one inch in diameter. The sleepiness and tiredness were gone within 24 hrs. The itchy and sore part of my arm at and around the injection site lasted for about 5 days. I put on Benadryl cream and took Tylenol and that helped. I also put on aspercream to take away some of the pain because I'm a side sleeper and it hurt to sleep on that side. Today is Sunday (3/7/21) and there is no more itchiness or pain but I still feel a little hard bump when I rub around the site of the injection. That doesn't bother me because the sore arm and itchiness at the site of the injection are gone.
Patient given expired vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient given expired vaccine) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 05-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient given expired vaccine). On 05-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patient given expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Co-suspect product Pfizer vaccine details were updated.
I came home after the shot, I ate some dinner and I was sitting in the sofa and my heart started to race really fast. I looked at my Apple Watch and it said it was over 190. I kept checking it. It didn't go down, it went up to 195 to 198 and my son drove me to urgent care. They did an EKG and it was normal. A few days following had momentarily moments when it came back. I did see a cardiologist and I was monitored. But since it did not continue, nothing came from it. It left as fast as it came.
Swelling; muscle pain; Chills; "strong reaction"; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT ("strong reaction"), MYALGIA (Myalgia), MYALGIA (muscle pain), CHILLS (Chills) and SWELLING (Swelling) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced ADVERSE EVENT ("strong reaction") and MYALGIA (Myalgia). On 17-May-2021, the patient experienced MYALGIA (muscle pain) and CHILLS (Chills). On 18-May-2021, the patient experienced SWELLING (Swelling). On 18-Apr-2021, ADVERSE EVENT ("strong reaction") and MYALGIA (Myalgia) had resolved. On 18-May-2021, MYALGIA (muscle pain) and SWELLING (Swelling) had resolved and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Headache; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache ".  Additional information: patient was experiencing a headache and wondering if she can take a pain reliever.  No follow-up attempts are possible. No further information is expected.
Hives; raised weals, intense itching and joint inflammation all over the body. Extreme sensitivity to hot water. Taking Loratadine.
Mom stated about 8pm (day of shots) child was sitting on dad's lap, slumped and quit breathing. Started hitting head, lasted about one minute. They shook her and started breathing. Watched no further problem.
off and on dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (off and on dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced DIZZINESS (off and on dizziness). At the time of the report, DIZZINESS (off and on dizziness) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable   Reporter did not allow further contact
I contracted Pericarditis as a result of vaccine. My Cardiologist had other patients to contract the same thing as a result of the Moderna vaccine.
Warmth; Pain at injection site; Itchy; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warmth), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported    Reporter did not allow further contact
pt rec'd grey cap pfizer vaccine after being stored in freezer for 22 days- deciding on comign in for replacement dose
Onset of dizziness and fullness in head. I drank water and rested in bed. When I kept my head still, I felt ok. When I moved my head, the dizziness returned. I fell asleep after a hour. When I woke up, the dizziness was less but was still driven by head movement. Dizziness lessened over the course of time and went away 04/20/2017 7:00 PM.
More than 36 days have passed and received 2nd dose after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days have passed and received 2nd dose after 1st dose) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days have passed and received 2nd dose after 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days have passed and received 2nd dose after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medications were not provided.
Twelve days post vax, on 08/25 the pt developed a generalized classic rash that consisted of an unknown number of lesions. The pt was afebrile. Follow up information from a physician reported that the pt went elsewhere for his diagnostic and work up. No further information available on the pt.
Short seizure followed by fever 104 degrees max - relieved with antipyretic. Mother declined to bring child to doctors.
Tested NAAT positive for COVID 10/21/21 after being fully vaccinated.
Deep Vein Thrombosis of left upper extremity in left subclavian vein that does not extend to SVC.  No known cause for this.  Started on Xarelto on 7/9/21.  Swelling in left upper extremity remains on 7/16/21.  Tolerating Xarelto well.
Site: Itching at Injection Site-Severe, Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Hypertension-Severe, Additional Details: the patient started having severe itchiness and gave them benadryl. they went to the urgent care and they gave her benadryl and prednisone, she stayed at the hospital for 1 day and now she is on prednisone 40 mg daily and gave her fexofenidine 180 mg and pepcid 20 mg
Patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received dose from vials beyond 30-day use by date) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received dose from vials beyond 30-day use by date). On 30-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patients received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter   The date of refrigeration was 07 May 2021   This case was linked to MOD-2021-365189 (Patient Link).
This spontaneous report was received from a registered nurse refers to a female patient of unknown age. It was reported that the patient noted on an medical history questionnaire that she had an unspecified reaction to an unspecified pneumonia vaccine (manufacturer unknown) on an unspecified date that possibly may have been PNEUMOVAX 23 (dose, route and lot # not reported). The outcome was not reported. Additional information is not expected.
Nausea, vomiting, diarrhea, fever, headache, weakness.
20 minutes after shot became flushed in face and hot. Subsided within 15 minutes. Approx 1 hour after injection experienced elevated heart rate (above 125) when in a sitting/sedentary state. 24 hours (approx) post vaccine experienced another short episode of elevated heart rate.
pt recvd vax 15JUN95 & over the next 2 wks pt devel varicella like rash on torso & later leg;also devel a mild fever, pt's MD reported that no adverse event or untoward rxn was reported to that ofc;
12/12 felt fine through out the day. When I got home I noticed a scratchy throat. The following morning my throat was worse and was hit with fatigue. 12/14 I felt a little better. 12/15 I developed cough, congestion, fatigue, and sneezing. 12/16 lost sense of smell and taste. Tested positive for COVID-19. 12/16 symptoms began to subside. 12/19 smell and taste began to return. 12/20 productive cough
Dermatographia; This spontaneous case was reported by a patient and describes the occurrence of MECHANICAL URTICARIA (Dermatographia) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H21B, 033B21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2022, the patient experienced MECHANICAL URTICARIA (Dermatographia). At the time of the report, MECHANICAL URTICARIA (Dermatographia) had not resolved.            No concomitant medications were taken at the time of event onset. Patient states that now he is on regular medication. Patient was given antiallergic medication for this symptom. He does not remember the name of this medication, but he only took it for one week because he did not see improvement. He is experiencing the symptoms since 4 months.
diarrhea; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a patient (husband). A 92-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on 20Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Feb2021 the patient experienced diarrhea. The reporter reported that they got the first dose yesterday together with elderly couple. She helped them to get the vaccine since they were of old age (both 92 years old). The elderly couple, the husband got diarrhea after the same dose. The outcome of event was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Swelling of arm down to elbow, couldn't bend elbow, no fever, swollen like a red apple, spreading to inner arm, fatigue, pulse 120.
Back Pain; ankle swelling; Foot pain; fever; Muscle pain, body pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), BACK PAIN (Back Pain) and JOINT SWELLING (ankle swelling) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), JOINT SWELLING (ankle swelling) and PAIN IN EXTREMITY (Foot pain). On an unknown date, the patient experienced BACK PAIN (Back Pain). At the time of the report, PYREXIA (fever), MYALGIA (Muscle pain, body pain), HEADACHE (Headache), BACK PAIN (Back Pain), JOINT SWELLING (ankle swelling) and PAIN IN EXTREMITY (Foot pain) outcome was unknown. Not Provided          No concomitant medication reported.  Treatment for the event include paracetamol and Ibuprofen.  Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact
Arm is still hurting; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and PAIN IN EXTREMITY (Arm is still hurting) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C20A and 031M20A) for COVID-19 vaccination.     No specified medical history has been reported.  Concomitant products included ATORVASTATIN, ACYCLOVIR [ACICLOVIR], MELOXICAM and TERAZOSIN for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced FATIGUE (fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is still hurting). At the time of the report, FATIGUE (fatigue) outcome was unknown and PAIN IN EXTREMITY (Arm is still hurting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: follow up received contain event outcome detail